Memorial Sloan Kettering Cancer Center is an Comprehensive Cancer Center located in New York, NY. Its mesothelioma program treats over 120 new patients annually and leads groundbreaking research in immunotherapy, targeted therapy, and surgical techniques for mesothelioma.
Last verified: 2026-03-09MSK's Mesothelioma Program is one of the largest dedicated programs in the world. The team has contributed to many of the landmark clinical trials that have shaped mesothelioma treatment standards. MSK's tumor board reviews every new mesothelioma case to develop a personalized treatment plan. The center also houses one of the most extensive mesothelioma tissue banks, enabling ongoing translational research.
MSK performs high-volume mesothelioma surgery including pleurectomy with decortication (their preferred approach for most pleural mesothelioma patients), extrapleural pneumonectomy for select cases, and cytoreductive surgery with HIPEC for peritoneal mesothelioma. The center leads multiple immunotherapy trials and was instrumental in the approval of nivolumab plus ipilimumab for mesothelioma.
Our team can help connect you with mesothelioma specialists at Memorial Sloan Kettering Cancer Center and explain your treatment options and legal rights.
Call 212-639-2000 to schedule an appointment. MSK offers the Patient Financial Services department, lodging assistance through partnerships with local hotels, an Integrative Medicine Service, and comprehensive survivorship programs. International patient services are available.
Phone: 212-639-2000
Website: mskcc.org/
Address: 1275 York Ave, New York, NY 10065
MSK is one of the world's leading mesothelioma treatment centers, treating over 120 new patients annually. It has been instrumental in many landmark mesothelioma clinical trials and treatment advances.
MSK generally favors pleurectomy with decortication (P/D) as its primary surgical approach for pleural mesothelioma, though EPP may be recommended for select patients. The choice depends on the individual patient's tumor characteristics and overall health.
Yes. MSK typically has 10-15 active mesothelioma clinical trials, including immunotherapy combinations, targeted therapies, and novel treatment approaches. MSK was central to the approval of nivolumab plus ipilimumab for mesothelioma.
Memorial Sloan Kettering Cancer Center in New York, NY is an NCI-designated Comprehensive Cancer Center offering mesothelioma treatment including surgery, immunotherapy, chemotherapy, and clinical trials. Contact the center directly to schedule a consultation or request a second opinion.
Memorial Sloan Kettering Cancer Center in New York is widely recognized as a leading mesothelioma treatment center in New York. As an NCI-designated Comprehensive Cancer Center, it offers specialized surgery, immunotherapy, chemotherapy, and clinical trials for mesothelioma patients.
If you or a loved one has been treated at Memorial Sloan Kettering Cancer Center for mesothelioma, our legal team can help you pursue the compensation you deserve while you focus on treatment. Contact us for a free, confidential consultation.
Or call us 24/7: 1-800-400-1805
Information last verified: 2026-03-09
Sources:
